Beijing Rimeng Biological Technology Co. Ltd. – FDA Inspection, Oct 11, 2017

Record Details

This FDA Inspection record concerns Beijing Rimeng Biological Technology Co. Ltd., with an inspection on October 11, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Beijing Rimeng Biological Technology Co. Ltd.
Inspection Date: October 11, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Meisha R. Sampson (Issuing Officer)

View Company Profile

ID · c8826ba2-fa54-484d-8249-361b7e23d883

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number: 1028830
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Beijing Rimeng Biological Technology Co. Ltd.

FDA Inspection

Beijing Rimeng Biological Technology Co. Ltd.October 11, 2017